Ardelyx | ARDX - Selling And Administration Expenses

Stock Price
7.80
Daily Change
0.01 0.06%
Monthly
28.00%
Yearly
47.35%
Q1 Forecast
7.45

Ardelyx reported $83.61M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Amgen USD 1.7B 9M Sep/2025
Ardelyx USD 83.61M 378K Sep/2025
aTyr Pharma USD 4.8M 130K Sep/2025
Corcept Therapeutics USD 106.97M 3.12M Sep/2025
Sanofi EUR 2.75B 455M Dec/2025
TG Therapeutics USD 63.37M 51.33M Sep/2025
United Therapeutics USD 152M 60.5M Sep/2025